SOPHiA GENETICS SA ROA 2020-2024 | SOPH
Current and historical return on assets (ROA) values for SOPHiA GENETICS SA (SOPH) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| SOPHiA GENETICS SA ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-12-31 | $-0.06B | $0.16B | -35.73% |
| 2024-09-30 | $-0.07B | $0.18B | -38.12% |
| 2024-06-30 | $-0.07B | $0.18B | -34.67% |
| 2024-03-31 | $-0.07B | $0.18B | -35.83% |
| 2023-12-31 | $-0.08B | $0.21B | -36.45% |
| 2023-09-30 | $-0.07B | $0.21B | -30.50% |
| 2023-06-30 | $-0.08B | $0.22B | -32.84% |
| 2023-03-31 | $-0.08B | $0.23B | -32.67% |
| 2022-12-31 | $-0.09B | $0.24B | -32.52% |
| 2022-09-30 | $-0.09B | $0.25B | -32.81% |
| 2022-06-30 | $-0.09B | $0.28B | -29.92% |
| 2022-03-31 | $-0.09B | $0.30B | -32.17% |
| 2021-12-31 | $-0.07B | $0.32B | -33.52% |
| 2021-09-30 | $-0.06B | $0.34B | -36.31% |
| 2021-06-30 | $-0.05B | $0.10B | -58.62% |
| 2021-03-31 | $-0.04B | $0.11B | -67.21% |
| 2020-12-31 | $-0.04B | $0.13B | -118.18% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.212B | $0.065B |
| SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.281B | 54.26 |
| Hims & Hers Health (HIMS) | United States | $12.358B | 128.40 |
| Tempus AI (TEM) | United States | $10.796B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.614B | 72.09 |
| IRhythm Technologies (IRTC) | United States | $4.399B | 0.00 |
| Privia Health (PRVA) | United States | $3.055B | 208.83 |
| Enovis (ENOV) | United States | $2.089B | 11.65 |
| Clover Health Investments (CLOV) | United States | $1.773B | 0.00 |
| Schrodinger (SDGR) | United States | $1.765B | 0.00 |
| Phreesia (PHR) | United States | $1.531B | 0.00 |
| Azenta (AZTA) | United States | $1.296B | 60.21 |
| Omnicell (OMCL) | United States | $1.286B | 22.69 |
| 10x Genomics (TXG) | United States | $1.161B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.613B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.581B | 0.00 |
| Talkspace (TALK) | United States | $0.515B | 154.00 |
| Veradigm (MDRX) | United States | $0.455B | 0.00 |
| Standard BioTools (LAB) | United States | $0.441B | 0.00 |
| TruBridge (TBRG) | United States | $0.395B | 875.67 |
| Claritev (CTEV) | United States | $0.353B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.315B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.204B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.151B | 0.00 |
| Pulmonx (LUNG) | United States | $0.148B | 0.00 |
| American Well (AMWL) | United States | $0.113B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.087B | 0.00 |
| CareCloud (CCLD) | United States | $0.086B | 3.27 |
| Retrieve Medical Holdings (RMHI) | United States | $0.083B | 0.00 |
| 111 (YI) | China | $0.068B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.061B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |